Skip to main content
HR 3105 116th Congress House Health Drug, alcohol, tobacco use Health care coverage and access Prescription drugs User charges and fees

Opioid Treatment Surge Act

Introduced: June 5, 2019 Introduced by: Bonamici, Suzanne Democratic · Oregon See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 6, 2019
Referred to the Subcommittee on Health.
Jun 5, 2019
Referred to the House Committee on Energy and Commerce.
Jun 5, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Opioid Treatment Surge Act

This bill requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.

What's happening now June 6, 2019

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2